BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 19164810)

  • 1. Vascular endothelial growth factor.
    Ferrara N
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):789-91. PubMed ID: 19164810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
    Ribatti D
    Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF in biological control.
    Breen EC
    J Cell Biochem; 2007 Dec; 102(6):1358-67. PubMed ID: 17979153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor receptors: expression and function in solid tumors.
    Wey JS; Stoeltzing O; Ellis LM
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropilins in physiological and pathological angiogenesis.
    Staton CA; Kumar I; Reed MW; Brown NJ
    J Pathol; 2007 Jul; 212(3):237-48. PubMed ID: 17503412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA; Rosenfeld PJ
    Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback mechanism between blood vessels and astrocytes in retinal vascular development.
    Kubota Y; Suda T
    Trends Cardiovasc Med; 2009 Feb; 19(2):38-43. PubMed ID: 19577710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic anti-VEGF antibodies.
    Lien S; Lowman HB
    Handb Exp Pharmacol; 2008; (181):131-50. PubMed ID: 18071944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive and inducible expression and regulation of vascular endothelial growth factor.
    Xie K; Wei D; Shi Q; Huang S
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):297-324. PubMed ID: 15450248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.
    Crawford Y; Ferrara N
    Trends Pharmacol Sci; 2009 Dec; 30(12):624-30. PubMed ID: 19836845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular endothelial growth factor--structure and functions].
    Barańska P; Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2005; 51(1):12-21. PubMed ID: 16209337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF inhibition: insights from preclinical and clinical studies.
    Crawford Y; Ferrara N
    Cell Tissue Res; 2009 Jan; 335(1):261-9. PubMed ID: 18766380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo.
    Lowe J; Araujo J; Yang J; Reich M; Oldendorp A; Shiu V; Quarmby V; Lowman H; Lien S; Gaudreault J; Maia M
    Exp Eye Res; 2007 Oct; 85(4):425-30. PubMed ID: 17714704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological consequences of VEGF-induced vascular permeability.
    Weis SM; Cheresh DA
    Nature; 2005 Sep; 437(7058):497-504. PubMed ID: 16177780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction.
    Sauer H; Wartenberg M
    Circ Res; 2008 Oct; 103(9):907-9. PubMed ID: 18948627
    [No Abstract]   [Full Text] [Related]  

  • 20. VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic.
    Epstein RJ
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):443-52. PubMed ID: 17786538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.